Ginsenoside Re aconazole D8 MM-102 was suggested to be

MM-102 was suggested to be used at 10-100 µM final concentration in vitro and in cellular assays

Ampiroxicam (50 μM) results in increased phosphorylation of MAPK1/2 in Panc-1 cells and L3

Endurobol was entered into clinical development as a drug candidate for metabolic diseases and cardiovascular diseases

Chemical Name: (2S)-2-amino-3-(4-{2-amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2

Ginsenoside Re aconazole D8 MM-102 was suggested to beGinsenoside Re is a PPAR agonist found in species of Panax. It inhibis formation of gastric mucosal lesions, decreases neutrophil infiltration, stimulates CD4+ T cell production, suppresses histamine release in mast cells, and prevents stress induced anxiety, depression and cognitive deficits. Product information CAS Number: 52286 59 6 Molecular Weight: 947. 15 Formula: C48H82O18 Synonym: Ginsenoside B2 Panaxoside Re Chikusetsusaponin IVc Sanchinoside